Do vaccines need informed consent?
There is no Federal requirement for informed consent relating to immunization. For state and local regulations, check with your local or state health department.
How is the MenACWY vaccine administered?
Administer meningococcal conjugate (MenACWY) and serogroup B meningococcal (MenB) vaccines by the intramuscular route. The preferred site for infants and young children is the vastus lateralis muscle in the anterolateral thigh. The preferred injection site in older children and adults is the deltoid muscle.
How is Menveo vaccine administered?
Each dose of MENVEO should be administered as a single 0.5-mL intramuscular injection, preferably into the anterolateral aspect of the thigh in infants or into the deltoid muscle (upper arm) in toddlers, adolescents, and adults. Do not administer MENVEO intravenously, subcutaneously, or intradermally.
How do you administer nimenrix?
Nimenrix will be given to you by a doctor or nurse. Nimenrix is always injected into a muscle, usually in the upper arm or thigh. Infants from 6 weeks to less than 6 months of age Two injections given 2 months apart at e.g. 2 and 4 months of age (the first injection may be given from the age of 6 weeks).
What is informed voluntary consent?
What is informed consent? Informed consent is one of the founding principles of research ethics. Its intent is that human participants can enter research freely (voluntarily) with full information about what it means for them to take part, and that they give consent before they enter the research.
Where is the MenACWY vaccine given?
The MenACWY vaccine is given by a single injection into the upper arm and protects against 4 strains of the meningococcal bacteria – A, C, W and Y – which cause meningitis and blood poisoning (septicaemia).
When should the meningococcal vaccine be administered?
Who should get the meningococcal vaccines? All children ages 11 through 12 years should receive meningococcal vaccine (MenACWY) followed by a booster dose at age 16 years. Vaccination is also recommended for all adolescents ages 13 through 18 years who did not receive a dose at age 11-12 years.
What is the difference between Menveo and Menactra?
A1: Menveo and Menactra are two brands of MenACWY vaccine. Menveo is licensed for administration to individuals 2 months through 55 years of age, whereas Menactra is licensed for administration to individuals 9 months through 55 years of age.
When should nimenrix be given?
Your baby will receive one dose given from 6 months of age. A booster dose is recommended at 12 months of age, with an interval of at least 2 months after the initial dose. Children from 12 months of age and adults: Most people will be given one NIMENRIX injection.
Does nimenrix need to be reconstituted?
NIMENRIX must be reconstituted by adding the entire contents of the pre-filled syringe of solvent to the vial containing the powder.
Is MenACWY a live vaccine?
The vaccine does not contain any live bacteria, and it cannot cause meningococcal disease. The MenACWY vaccine was introduced in the UK in summer 2015 because of the recent increase in cases of MenW disease in the UK (see ‘More information about the vaccine’ below).
Why is meningococcal B vaccine not on schedule?
A NSW Health spokeswoman said the federal Pharmaceutical Benefits Advisory Committee (PBAC) had assessed the meningococcal B vaccine three times and had determined it didn’t meet funding criteria.
Can menveo and Prevnar 13 be given together?
If these vaccines are inadvertently administered on the same day, Prevenar 13® should be repeated a minimum of 8 weeks later. Menveo® and Nimenrix® may be co-administered with Prevenar 13®.
Can nimenrix and Prevnar 13 be given together?
If both vaccines are required, Prevenar 13® should be administered first followed by Menactra® at least 4 weeks later. If these vaccines are inadvertently administered on the same day, Prevenar 13® should be repeated a minimum of 8 weeks later. Menveo® and Nimenrix® may be co-administered with Prevenar 13®.